GLOBAL NEUROSCIENCES INSTITUTE

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Emergent Prep for IV Dye in Acute Stroke Patients With Allergy

First Posted Date
2023-06-15
Last Posted Date
2023-06-15
Lead Sponsor
Global Neurosciences Institute
Target Recruit Count
50
Registration Number
NCT05905900

Verapamil for Neuroprotection in Stroke

Phase 1
Conditions
Ischemic Stroke
First Posted Date
2017-11-20
Last Posted Date
2022-08-10
Lead Sponsor
Global Neurosciences Institute
Target Recruit Count
20
Registration Number
NCT03347786
Locations
🇺🇸

Crozer Keystone Health System, Upland, Pennsylvania, United States

Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme

Phase 1
Recruiting
Conditions
Glioblastoma Multiforme
Interventions
Drug: Bevacizumab
First Posted Date
2014-11-07
Last Posted Date
2022-08-10
Lead Sponsor
Global Neurosciences Institute
Target Recruit Count
30
Registration Number
NCT02285959
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy